Masti veyxym
Masti veyxym
Authorised
- DL-ALPHA TOCOPHEROL ACETATE
- Retinol
- Chymotrypsin
- Trypsin
- Papain
Product identification
Medicine name:
Masti veyxym
Active substance:
- DL-ALPHA TOCOPHEROL ACETATE
- Retinol
- Chymotrypsin
- Trypsin
- Papain
Target species:
-
Cattle (dairy cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
DL-ALPHA TOCOPHEROL ACETATE120.00milligram(s)1.00Syringe
-
Retinol100000.00international unit(s)1.00Syringe
-
Chymotrypsin2400.00FIP1.00Syringe
-
Trypsin240.00FIP1.00Syringe
-
Papain6.00FIP1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cow)
-
Milk1day
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QD03B
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Romania
Available in:
-
Romania
Package description:
- Available only in Romanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone) - Directive No 2001/82/EC
Marketing authorisation holder:
- Veyx Pharma GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Veyx Pharma GmbH
Responsible authority:
- Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
- 110200
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Romanian (PDF)
Published on: 6/06/2023
Updated on: 8/06/2023
How useful was this page?: